Why Abaxis Shares Sank

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Abaxis (NASDAQ: ABAX  ) plunged 11% today after the blood analysis systems company posted disappointing quarterly results.

So what: Abaxis got axed in July on signs of slowing growth, and today's Q2 results -- earnings declined 72% to $5.7 million on a revenue increase of just 4% -- only reinforce that worrisome trend. In fact, gross margin for the quarter fell 450 basis points to 47.7%, suggesting that its competitive position is weakening rather quickly.

Now what: While Abaxis hasn't given up on year-over-year growth in 2013, management admits that it likely won't happen.

"[A]ll the work that's being done with retail and with clinical research and with the opportunity we have in Canada and the stuff that's going on in Europe, I mean clearly those are huge upsides that are probably not going to happen this fiscal year," Chairman and CEO Clinton Severson said in a conference call. "Now some of it is going to happen this fiscal year but not the really big numbers."

With the stock now off 35% from its 52-week highs, now might be an opportune time to bet on a turnaround in 2014. 

More compelling health care picks
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In The Motley Fool's brand-new FREE report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2695310, ~/Articles/ArticleHandler.aspx, 9/29/2016 4:41:28 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 6 hours ago Sponsored by:
DOW 18,339.24 110.94 0.61%
S&P 500 2,171.37 11.44 0.53%
NASD 5,318.55 12.84 0.24%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/28/2016 4:00 PM
ABAX $50.88 Up +0.04 +0.08%
Abaxis CAPS Rating: *****